Smoking and health outcomes after percutaneous coronary intervention

American Heart Journal

Volumn 145, Issue 4, 2003, Pages 652-657

  Haddock, C Keith ^a,b   Poston, Walker S C ^a   Taylor, Jennifer E ^a   Conard, Mark ^a   Spertus, John ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH STATUS; HEALTH SURVEY; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; SMOKING; STATISTICAL SIGNIFICANCE; UNITED STATES;

EID: 0037383923     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2003.67     Document Type: Article

References (26)

1. Smith SC, Dove JT, Jacobs AK, et al. ACC/AHA guidelines for percutaneous coronary (revision of the 1993 PTCA guidelines). J Am Coll Cardiol 2001;37:2215-39.
2. Hong MK, Kornowski R, Bramwell O, et al. Paclitaxel-coated Gianturco-Roubin II (GR-II) stents reduce neointimal hyperplasia in a porcine coronary in-stent restenosis model. Coron Artery Dis 2001;12:513-5.
3. Violaris AG, Thury A, Regar E, et al. Influence of a history of smoking on short term (six months) clinical and angiographic outcome after successful coronary angioplasty. Heart 2000;84:299-306.
4. Hasdai DKN, Garratt KN, Grill DE, et al. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med 1997;336:755-61.
5. Jorgensen B, Endresen K, Forfang K, et al. Attenuated physical exercise capacity in smokers compared with non-smokers after coronary angioplasty despite similar luminal diameters. Eur Heart J 1998;19:737-41.
6. Taira DA, Seto TB, Ho KK, et al. Impact of smoking on health-related quality of life after percutaneous coronary revascularization. Circulation 2000;102:1369-74.
7. Ware JE, Snow KK, Kosinski M, et al. SF-36 health survey: manual and interpretation guide. Boston (Mass): The Health Institute, New England Medical Center; 1993.
8. Attebring MF, Hartford M, Holm G, et al. Risk indicators for recurrence among patients with coronary artery disease: problems associated with their modification. Scand Cardiovasc J 1998;32:9-16.
9. Spertus JA, Bliven BD, Farner M, et al. Integrating baseline health status data collection into the process of care. Jt Comm J Qual Improv 2001;27:369-80.
10. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II: psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63.
11. Spertus JA, Winder JA, Dewhurst TA, et al. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol 1994;74:1240-4.
12. Dougherty CM, Newhurst T, Nichol WP, et al. Comparison of three quality of life instruments in stable angina pectoris: Seattle Angina Questionnaire, Short Form Health Survey (SF-36), and Quality of Life Index-Cardiac Version III. J Clin Epidemiol 1998;51:569-75.
13. Spertus J, Winder J, Dewhurst T, et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 1995;25:333-41.
14. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures: statistics and strategies for evaluation. Control Clin Trials 1991;12:14-58S.
15. Cucherat M, Bonnefoy E, Tremeau G. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction [computer file]. Cochrane Database Syst Rev 2000;2:CD001560.
16. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Iib/IIIa inhibitor triofiban. N Engl J Med 2001;344;1879-87.
17. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence. Clinical Practice Guideline. Rockville (Md): US Department of Health and Human Services, Public Health Service; June 2000.
18. Stein RJ, Haddock CK, O'Byrne KK, et al. The pediatrician's role in reducing tobacco exposure in children. Pediatrics 2000;106:e66.
19. Benowitz NL. Treatment of nicotine dependence in clinical cardiology. CVD Prev 1999;2:135-9.
20. Garfield J. Controversies in treatment: should smokers be offered coronary bypass surgery? Let the Health Authority take the responsibility [letter]. BMJ 1993;306:1050.
21. Odom NJ, Ashraf SS, Sharif MH, et al. Access to heart surgery for smokers. BMJ 1993;307:128-9.
22. Underwood MJ, Bailey JS. Coronary bypass surgery should not be offered to smokers. BMJ 1993;306:1047-9.
23. Mogielnicki RP, Bell J, Fowler FJ. The influence of patient smoking status on therapeutic decisions. J Gen Intern Med 1992;7:165-9.
24. Velicer WF, Prochaska JO, Rossi JS, et al. Assessing outcome in smoking cessation studies. Psychol Bull 1992;111:23-41.
25. Glasgow RE, Mullooly JP, Vogt TM, et al. Biochemical validation of smoking status in public health settings: pros, cons, and data from four low intensity interventions trials. Addict Behav 1992;18:504-27.
26. Patrick DL, Cheadle A, Thompson DC, et al. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health 1994;84:1086-93.